Clinical Focus

• Medical Oncology
• Breast cancer

Administrative Appointments

• Medical Director, Stanford Cancer Center (2010 - present)
• Medical Director, University of Michigan Comprehensive Cancer Center (2003 - 2010)
• President, Wilshire Oncology Medical Group, Inc. (1996 - 2003)

Honors and Awards

• President, American Society of Clinical Oncology (2009-10)

Professional Education

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industrial and other commercial partners. It is our policy to disclose payments (exclusive of travel support) from, and/or equity in, companies or other commercial entities to Stanford faculty of $5,000 or more in total value, as well as any equity in a privately held company, when the faculty member also has institutional responsibilities related to his or her interactions with the company. View Full Information

Current Research Interests

Use of medical informatics to improve quality delivery in cancer care

Clinical Trials

• Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Recruiting

Publications

• American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology. Schnipper LE, Smith TJ, Raghavan D, Blayney DW, Ganz PA, Mulvey TM, Wollins DS. J Clin Oncol. 2012
• Michigan oncology practices showed varying adherence rates to practice guidelines, but quality interventions improved care. Blayney DW, Severson J, Martin CJ, Kadlubek P, Ruane T, Harrison K. Health Aff (Millwood). 2012; 31 (4): 718-28
• Enhancing quality through innovation: American Society of Clinical Oncology presidential address 2010. Blayney DW, J Clin Oncol. 2010; 28 (28): 4283-8
• Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center. Blayney DW, McNiff K, Hanauer D, Miela G, Markstrom D, Neuss M. J Clin Oncol. 2009; 27 (23): 3802-7
• Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma. Blayney DW, McGuire BW, Cruickshank SE, Johnson DH. Oncologist. 2005; 10 (2): 138-49